GGrantIndex
Sort

261,768 grants matching gene therapy

Longitudinal Assessment of Manic Symptoms

$1,147,958
Boris Birmaher · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · MH

Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome

$1,147,757
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Intrabiliary MR/RF-enhanced chemotherapy of malignant biliary obstructions

$1,147,702
Xiaoming Yang · University Of Washington · R01 · FY2014 · EB

Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy

$1,147,554
Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA

Childhood Cancer Data Initiative

$1,147,549
Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZID · FY2025 · CA

Roswell Park Ovarian Cancer SPORE

$1,147,484
Kirsten B Moysich · Roswell Park Cancer Institute Corp · P50 · FY2023 · CA

Bastyr/UW Oncomycology Translational Research Center

$1,147,443
Leanna J Standish · Bastyr University · U19 · FY2010 · AT

Immuno/Immuno-Gene Therapies for Thoracic Malignancies

$1,147,325
Steven Mark Albelda · University Of Pennsylvania · P01 · FY2014 · CA

Cincinnati Multidisciplinary Clinical Research Center

$1,147,244
Daniel Joe Lovell · Cincinnati Childrens Hosp Med Ctr · P60 · FY2012 · AR

Interventional approaches for restoring vision

$1,147,236
Anand Swaroop · National Eye Institute · ZIA · FY2011 · EY

SLEEP, AGING AND CIRCADIAN RHYTHM DISORDERS

$1,147,092
Brigham And Women'S Hospital · P01 · FY2000 · AG

The Hepato/Renal Fibrocystic Disease Core Center

$1,146,946
Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2015 · DK

Molecular Determinants of Statin Efficacy and Adverse Effects in Cellular Models

$1,146,873
Marisa Wong Medina · Children'S Hospital & Res Ctr At Oakland · P50 · FY2017 · GM

Molecular Epidemiology of Parkinson's Disease

$1,146,714
Demetrius Michael Maraganore · Endeavor Health Clinical Operations · R01 · FY2010 · ES

Multicenter Network of Maternal-Fetal Medicine Units

$1,146,697
University Of Utah · U10 · FY2002 · HD

SBIR: In vivo engineering of multifaceted B7H3.CAR-T cells for cellular immunotherapy of pancreatic ductal adenocarcinoma

$1,146,618
Ming Yang · Mucommune, Llc · R44 · FY2025 · CA

Epi-genetic Programs in Cancer Progression

$1,146,600
Robert A Weinberg · Whitehead Institute For Biomedical Res · R35 · FY2023 · CA

Epi-genetic Programs in Cancer Progression

$1,146,600
Robert A Weinberg · Whitehead Institute For Biomedical Res · R35 · FY2022 · CA

Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging

$1,146,490
Xianyu S Hou · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)

$1,146,463
Michael D Geschwind · University Of California, San Francisco · R01 · FY2022 · AG

Effects of genetic polymorphism in MHC, KIR, and related loci on human disease

$1,146,377
Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models

$1,146,280
John Peter Wikswo · Vanderbilt University · UG3 · FY2017 · TR

MULTICENTER CLINICAL STUDY OF ALS GENETICS

$1,146,227
Northwestern University · R01 · FY2002 · NS

Genomics and Proteomics of Head and Neck Cancer

$1,146,221
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2014 · DC

SPORE in Skin Cancer

$1,146,135
Meenhard Herlyn · Wistar Institute · P50 · FY2009 · CA